MEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat - StreetInsider.com

Smarter Analyst

MEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat StreetInsider.com Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the ... Helsinn Teams Up with MEI Pharma to Develop AML Compound PracinostatGenetic Engineering & Biotechnology News MEI Pharma Partners with Helsinn on Drug with Potential $464M PayoffXconomy MEI Pharma lands major deal for cancer drug PracinostatThe San Diego Union-Tribune Seeking Alpha all 6 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFYN_FExqBTWxgWYR3AONEg7eRwfQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779176117688&ei=6ZmoV8CTOKPT3AHruYu4Cg&url=http://www.streetinsider.com/Corporate%2BNews/MEI%2BPharma%2B(MEIP),%2BHelsinn%2BEnter%2BDevelopment%2Band%2BCommercialization%2BAgreement%2Bfor%2BPracinostat/11912068.html
via IFTTT